Tuberostemonine may enhance the function of the SLC7A11/glutamate antiporter to restrain the ferroptosis to alleviate pulmonary fibrosis

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacotherapy +11

Characterization of ferroptosis in murine models of hemochromatosis

Hao Wang, Peng An, Enjun Xie et al. · Hepatology · 2017 · 669 citations · Full text

Life Sciences, Biochemistry, Physiology +15

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

Toby M. Maher, Tamera J. Corte, Aryeh Fischer et al. · The Lancet Respiratory Medicine · 2019 · 630 citations

Medicine, Clinical Sciences, Pharmacotherapy +6

Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis*

Ursula Heine, Eliana F. Munoz, Kathleen C. Flanders et al. · Development · 1990 · 224 citations

Life Sciences, Developmental Biology, Molecular Biology +17

Iron deposition-induced ferroptosis in alveolar type II cells promotes the development of pulmonary fibrosis

Haipeng Cheng, Dandan Feng, Xiaohong Li et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2021 · 122 citations

Medicine, Cell Biology, Pathology +12